Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

C Gaggiano; A Maselli; Pp Sfikakis; K Laskari; G Ragab; Mt Hegazy; Ah Laymouna; G Lopalco; Ia Almaghlouth; Kn Asfina; O Alahmed; Ha Giardini Mayrink; I Parente de Brito Antonelli; M Cattalini; M Piga; J Sota; S Gentileschi; Mc Maggio; D Opris-Belinski; G Hatemi; A Insalaco; An Olivieri; A Tufan; H Karadeniz; Rc Kardaş; F La Torre; F Cardinale; A Marino; S Guerriero; P Ruscitti; M Tarsia; A Vitale; V Caggiano; S Telesca; F Iannone; V Parretti; M Frassi; E Aragona; F Ciccia; E Wiesik-Szewczyk; R Ionescu; A Şahin; N Akkoç; A Hinojosa-Azaola; S Tharwat; J Hernández-Rodríguez; G Espinosa; G Conti; E Del Giudice; M Govoni; G Emmi; C Fabiani; A Balistreri; B Frediani; Donato Rigante; L Cantarini

doi:10.1007/s11739-023-03215-w

Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

C Gaggiano, A Maselli, Pp Sfikakis, K Laskari, G Ragab, Mt Hegazy, Ah Laymouna, G Lopalco, Ia Almaghlouth, Kn Asfina, O Alahmed, Ha Giardini Mayrink, I Parente de Brito Antonelli, M Cattalini, M Piga, J Sota, S Gentileschi, Mc Maggio, D Opris-Belinski, G HatemiA Insalaco, An Olivieri, A Tufan, H Karadeniz, Rc Kardaş, F La Torre, F Cardinale, A Marino, S Guerriero, P Ruscitti, M Tarsia, A Vitale, V Caggiano, S Telesca, F Iannone, V Parretti, M Frassi, E Aragona, F Ciccia, E Wiesik-Szewczyk, R Ionescu, A Şahin, N Akkoç, A Hinojosa-Azaola, S Tharwat, J Hernández-Rodríguez, G Espinosa, G Conti, E Del Giudice, M Govoni, G Emmi, C Fabiani, A Balistreri, B Frediani, Donato Rigante, L Cantarini

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.

Lingua originale	English
pagine (da-a)	743-754
Numero di pagine	12
Rivista	Internal and Emergency Medicine
Volume	2023
DOI	https://doi.org/10.1007/s11739-023-03215-w
Stato di pubblicazione	Pubblicato - 2023

Keywords

Autoinflammation
Behçet's disease

Accesso al documento

10.1007/s11739-023-03215-w

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Gaggiano, C., Maselli, A., Sfikakis, P., Laskari, K., Ragab, G., Hegazy, M., Laymouna, A., Lopalco, G., Almaghlouth, I., Asfina, K., Alahmed, O., Giardini Mayrink, H., Parente de Brito Antonelli, I., Cattalini, M., Piga, M., Sota, J., Gentileschi, S., Maggio, M., Opris-Belinski, D., ... Cantarini, L. (2023). Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry. Internal and Emergency Medicine, 2023, 743-754. https://doi.org/10.1007/s11739-023-03215-w

@article{f2e03c13ec374f9588347244cf82a82b,

title = "Musculoskeletal manifestations in children with Beh{\c c}et's syndrome: data from the AIDA Network Beh{\c c}et's Syndrome Registry",

abstract = "This study aims to describe musculoskeletal manifestations (MSM) in children with Beh{\c c}et{\textquoteright}s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Beh{\c c}et{\textquoteright}s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Beh{\c c}et's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.",

keywords = "Autoinflammation, Beh{\c c}et's disease, Autoinflammation, Beh{\c c}et's disease",

author = "C Gaggiano and A Maselli and Pp Sfikakis and K Laskari and G Ragab and Mt Hegazy and Ah Laymouna and G Lopalco and Ia Almaghlouth and Kn Asfina and O Alahmed and {Giardini Mayrink}, Ha and {Parente de Brito Antonelli}, I and M Cattalini and M Piga and J Sota and S Gentileschi and Mc Maggio and D Opris-Belinski and G Hatemi and A Insalaco and An Olivieri and A Tufan and H Karadeniz and Rc Karda{\c s} and {La Torre}, F and F Cardinale and A Marino and S Guerriero and P Ruscitti and M Tarsia and A Vitale and V Caggiano and S Telesca and F Iannone and V Parretti and M Frassi and E Aragona and F Ciccia and E Wiesik-Szewczyk and R Ionescu and A {\c S}ahin and N Akko{\c c} and A Hinojosa-Azaola and S Tharwat and J Hern{\'a}ndez-Rodr{\'i}guez and G Espinosa and G Conti and {Del Giudice}, E and M Govoni and G Emmi and C Fabiani and A Balistreri and B Frediani and Donato Rigante and L Cantarini",

year = "2023",

doi = "10.1007/s11739-023-03215-w",

language = "English",

volume = "2023",

pages = "743--754",

journal = "Internal and Emergency Medicine",

issn = "1828-0447",

publisher = "Milano : Springer Verlag Italia Roma : CEPI",

}

Gaggiano, C, Maselli, A, Sfikakis, P, Laskari, K, Ragab, G, Hegazy, M, Laymouna, A, Lopalco, G, Almaghlouth, I, Asfina, K, Alahmed, O, Giardini Mayrink, H, Parente de Brito Antonelli, I, Cattalini, M, Piga, M, Sota, J, Gentileschi, S, Maggio, M, Opris-Belinski, D, Hatemi, G, Insalaco, A, Olivieri, A, Tufan, A, Karadeniz, H, Kardaş, R, La Torre, F, Cardinale, F, Marino, A, Guerriero, S, Ruscitti, P, Tarsia, M, Vitale, A, Caggiano, V, Telesca, S, Iannone, F, Parretti, V, Frassi, M, Aragona, E, Ciccia, F, Wiesik-Szewczyk, E, Ionescu, R, Şahin, A, Akkoç, N, Hinojosa-Azaola, A, Tharwat, S, Hernández-Rodríguez, J, Espinosa, G, Conti, G, Del Giudice, E, Govoni, M, Emmi, G, Fabiani, C, Balistreri, A, Frediani, B, Rigante, D & Cantarini, L 2023, 'Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry', Internal and Emergency Medicine, vol. 2023, pagg. 743-754. https://doi.org/10.1007/s11739-023-03215-w

TY - JOUR

T1 - Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

AU - Gaggiano, C

AU - Maselli, A

AU - Sfikakis, Pp

AU - Laskari, K

AU - Ragab, G

AU - Hegazy, Mt

AU - Laymouna, Ah

AU - Lopalco, G

AU - Almaghlouth, Ia

AU - Asfina, Kn

AU - Alahmed, O

AU - Giardini Mayrink, Ha

AU - Parente de Brito Antonelli, I

AU - Cattalini, M

AU - Piga, M

AU - Sota, J

AU - Gentileschi, S

AU - Maggio, Mc

AU - Opris-Belinski, D

AU - Hatemi, G

AU - Insalaco, A

AU - Olivieri, An

AU - Tufan, A

AU - Karadeniz, H

AU - Kardaş, Rc

AU - La Torre, F

AU - Cardinale, F

AU - Marino, A

AU - Guerriero, S

AU - Ruscitti, P

AU - Tarsia, M

AU - Vitale, A

AU - Caggiano, V

AU - Telesca, S

AU - Iannone, F

AU - Parretti, V

AU - Frassi, M

AU - Aragona, E

AU - Ciccia, F

AU - Wiesik-Szewczyk, E

AU - Ionescu, R

AU - Şahin, A

AU - Akkoç, N

AU - Hinojosa-Azaola, A

AU - Tharwat, S

AU - Hernández-Rodríguez, J

AU - Espinosa, G

AU - Conti, G

AU - Del Giudice, E

AU - Govoni, M

AU - Emmi, G

AU - Fabiani, C

AU - Balistreri, A

AU - Frediani, B

AU - Rigante, Donato

AU - Cantarini, L

PY - 2023

Y1 - 2023

N2 - This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.

AB - This study aims to describe musculoskeletal manifestations (MSM) in children with Behçet’s syndrome (BS), their association with other disease manifestations, response to therapy, and long-term prognosis. Data were retrieved from the AIDA Network Behçet’s Syndrome Registry. Out of a total of 141 patients with juvenile BS, 37 had MSM at disease onset (26.2%). The median age at onset was 10.0 years (IQR 7.7). The median follow-up duration was 21.8 years (IQR 23.3). Recurrent oral (100%) and genital ulcers (67.6%) and pseudofolliculitis (56.8%) were the most common symptoms associated with MSM. At disease onset, 31 subjects had arthritis (83.8%), 33 arthralgia (89.2%), and 14 myalgia (37.8%). Arthritis was monoarticular in 9/31 cases (29%), oligoarticular in 10 (32.3%), polyarticular in 5 (16.1%), axial in 7 (22.6%). Over time, arthritis became chronic-recurrent in 67.7% of cases and 7/31 patients had joint erosions (22.6%). The median Behçet's Syndrome Overall Damage Index was 0 (range 0–4). Colchicine was inefcacious for MSM in 4/14 cases (28.6%), independently from the type of MSM (p=0.46) or the concomitant therapy (p=0.30 for cDMARDs, p=1.00 for glucocorticoids); cDMARDs and bDMARDs were inefcacious for MSM in 6/19 (31.4%) and 5/12 (41.7%) cases. The presence of myalgia was associated with bDMARDs inefcacy (p=0.014). To conclude, MSM in children with BS are frequently associated with recurrent ulcers and pseudofolliculitis. Arthritis is mostly mono- or oligoarticular, but sacroiliitis is not unusual. Prognosis of this subset of BS is overall favorable, though the presence of myalgia negatively afects response to biologic therapies.

KW - Autoinflammation

KW - Behçet's disease

KW - Autoinflammation

KW - Behçet's disease

UR - http://hdl.handle.net/10807/232827

U2 - 10.1007/s11739-023-03215-w

DO - 10.1007/s11739-023-03215-w

M3 - Article

SN - 1828-0447

VL - 2023

SP - 743

EP - 754

JO - Internal and Emergency Medicine

JF - Internal and Emergency Medicine

ER -

Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo